Total Payments
$509.39
2020 Payments
$129.86
Companies
14
Transactions
38
Medicare Patients
2,872
Medicare Billing
$459,805
Payment Breakdown by Category
Food & Beverage$504.01 (98.9%)
Education$5.38 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $504.01 | 36 | 98.9% |
| Education | $5.38 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $104.56 | 7 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $85.96 | 8 | $0 (2020) |
| GlaxoSmithKline, LLC. | $80.10 | 6 | $0 (2020) |
| Novo Nordisk Inc | $38.08 | 3 | $0 (2018) |
| PFIZER INC. | $37.02 | 3 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $25.38 | 2 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.02 | 1 | $0 (2018) |
| US WorldMeds, LLC | $24.71 | 2 | $0 (2020) |
| Eisai Inc. | $17.36 | 1 | $0 (2020) |
| AbbVie, Inc. | $17.29 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $129.86 | 9 | Sunovion Pharmaceuticals Inc. ($32.68) |
| 2019 | $23.47 | 2 | GlaxoSmithKline, LLC. ($23.47) |
| 2018 | $249.41 | 18 | SANOFI-AVENTIS U.S. LLC ($57.29) |
| 2017 | $106.65 | 9 | PFIZER INC. ($37.02) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: CNS | ||||||
| 09/01/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $17.36 | General |
| Category: Neurology | ||||||
| 07/23/2020 | US WorldMeds, LLC | Lucemyra (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 06/22/2020 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Psychiatry/Psychology | ||||||
| 04/30/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: RESPIRATORY | ||||||
| 04/08/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/26/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: CNS | ||||||
| 02/07/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO ELLIPTA | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: RESPIRATORY | ||||||
| 01/15/2020 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Endocrinology | ||||||
| 08/23/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: RESPIRATORY | ||||||
| 06/06/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: DIABETES | ||||||
| 10/03/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: DIABETES | ||||||
| 09/24/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2018 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Respiratory | ||||||
| 08/15/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Diabetes | ||||||
| 08/08/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Diabetes | ||||||
| 08/01/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: DIABETES | ||||||
| 07/20/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: DIABETES | ||||||
| 07/18/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Immunology | ||||||
| 07/06/2018 | Sunovion Pharmaceuticals Inc. | Utibron (Drug), Seebri, Lonhala Magnair | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Respiratory | ||||||
| 06/19/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/06/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Central Nervous System (CNS) | ||||||
| 05/30/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/23/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 409 | 1,143 | $153,306 | $58,234 |
| 2022 | 12 | 578 | 1,552 | $249,935 | $104,135 |
| 2021 | 12 | 755 | 2,085 | $305,356 | $136,081 |
| 2020 | 19 | 1,130 | 3,013 | $414,217 | $161,355 |
Total Patients
2,872
Total Services
7,793
Medicare Billing
$459,805
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 337 | $64,832 | $26,668 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 120 | 408 | $55,031 | $23,255 | 42.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 51 | $13,680 | $5,574 | 40.7% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 50 | 211 | $1,248 | $812.35 | 65.1% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 13 | 57 | $15,561 | $703.95 | 4.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 12 | 14 | $1,344 | $567.70 | 42.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 12 | 15 | $731.85 | $316.38 | 43.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 28 | 31 | $775.00 | $295.12 | 38.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 19 | $102.60 | $41.80 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 512 | $98,323 | $39,829 | 40.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 145 | 356 | $47,946 | $20,706 | 43.2% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 13 | 84 | $25,041 | $16,414 | 65.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 78 | 137 | $36,749 | $15,193 | 41.3% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 15 | 116 | $31,668 | $7,108 | 22.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $4,914 | $2,198 | 44.7% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 59 | 213 | $1,257 | $827.01 | 65.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 15 | 16 | $1,536 | $650.05 | 42.3% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 19 | 26 | $1,269 | $641.35 | 50.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 32 | 40 | $810.00 | $386.66 | 47.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 14 | $299.60 | $131.30 | 43.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 18 | 23 | $124.20 | $51.04 | 41.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 230 | 905 | $164,246 | $78,211 | 47.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 120 | 194 | $50,095 | $23,990 | 47.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 139 | 279 | $34,872 | $15,521 | 44.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 26 | 143 | $32,196 | $8,369 | 26.0% |
About Dr. Wilson Tabe, MD
Dr. Wilson Tabe, MD is a Family Medicine healthcare provider based in Goldsboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679551949.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wilson Tabe, MD has received a total of $509.39 in payments from pharmaceutical and medical device companies, with $129.86 received in 2020. These payments were reported across 38 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($504.01).
As a Medicare-enrolled provider, Tabe has provided services to 2,872 Medicare beneficiaries, totaling 7,793 services with total Medicare billing of $459,805. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Goldsboro, NC
- Active Since 01/05/2006
- Last Updated 04/24/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679551949
Products in Payments
- TOUJEO (Drug) $70.30
- TRELEGY ELLIPTA (Drug) $45.18
- BREO (Drug) $34.92
- LATUDA (Drug) $32.68
- Victoza (Drug) $25.18
- TRADJENTA (Drug) $25.02
- LYRICA (Drug) $24.10
- UTIBRON (Drug) $22.64
- SOLIQUA (Drug) $21.22
- LONHALA MAGNAIR (Drug) $18.60
- Dayvigo (Drug) $17.36
- Humira (Biological) $17.29
- INVOKANA (Drug) $13.64
- TRULANCE (Drug) $13.45
- TOUJEO (Biological) $13.04
- CHANTIX (Drug) $12.92
- Tresiba (Drug) $12.90
- Lucemyra/Lofexidine (Drug) $12.71
- Trintellix (Drug) $12.67
- LINZESS (Drug) $12.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Goldsboro
Dr. Dimitrios Lintzeris, D.o, D.O
Family Medicine — Payments: $110,192
Family Medicine $110,192
Donald Clarke, Md, MD
Family Medicine — Payments: $13,159
Family Medicine $13,159
Dr. Phillip Moye, M.d, M.D
Family Medicine — Payments: $10,278
Family Medicine $10,278
Dr. Carolyn Sampson, M.d, M.D
Family Medicine — Payments: $5,597
Family Medicine $5,597
Keith Carmack, M.d, M.D
Family Medicine — Payments: $3,631
Family Medicine $3,631
Dr. Shannon Jimenez, D.o, D.O
Family Medicine — Payments: $3,496
Family Medicine $3,496